Bone hydroxyapatite hydroxide lattice site (HAp OH- site)

Bone hydroxyapatite is the primary inorganic component of bone and tooth enamel, providing the necessary hardness and structural integrity to the skeletal system (StatPearls: Bone Development and Structure). The hydroxide (OH-) lattice sites within this crystalline structure are essential for the mineral's chemical properties and serve as the primary site for ion exchange reactions. Pharmacologically, these sites are targeted by fluoride ions, which substitute for the hydroxide groups to create fluorapatite, a mineral phase that is significantly more resistant to acid dissolution and bacterial degradation (NIH: Fluoride Fact Sheet). This substitution is a cornerstone of dental health for preventing caries and has been explored in the treatment of osteoporosis to increase bone mass (PubMed: PMCID PMC3444548). However, the therapeutic window is narrow, as excessive incorporation of foreign ions into the lattice can lead to fluorosis, characterized by mottled enamel and increased skeletal fragility (PubChem: Sodium Fluoride).

Other names

Hydroxyapatite hydroxyl siteBone mineral lattice siteHydroxyl position in hydroxyapatiteHydroxyapatite OH- position

Ion substitution where fluoride or other ions replace the hydroxide group in the crystal lattice to form a more stable and less soluble mineral phase (fluorapatite).